published meta-analysis   sensitivity analysis   studies

Renin-angiotensin-system-acting agents in COVID-19 prophylaxis (excluding children) - Summary of results

OutcomeTE95% CInkI2ROBPub. bias new illness compatible with Covid-19 detailed resultsMancia, 2020 0.95 [0.86; 1.05] Morales, 2020 0.98 [0.84; 1.14] Reynolds (prophylaxis), 2020 1.08 [0.95; 1.24] 0.99[0.92; 1.07]Mancia, 2020, Morales, 2020, Reynolds (prophylaxis), 2020315%3,384moderatenot evaluable0.52.01.0relative treatment effectwww.metaEvidence.org2024-06-12 12:20 +02:00

TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers); k: number of studies; n: total number of patients; ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1; studied treatment is better when TE < 1;

pathologies: 89 - treatments: 612,552,590,891,605,892,722,618,609 - roots T: 290